Copyright
©The Author(s) 2020.
World J Clin Cases. Jan 6, 2020; 8(1): 11-19
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.11
Published online Jan 6, 2020. doi: 10.12998/wjcc.v8.i1.11
Figure 4 Tc17 cell-derived interleukin-17 induces tumor cells to produce CXCL12.
A: Primary tumor cells were cultured with various concentrations of interleukin (IL)-17, IL-22, interferon-γ, and the production of CXC12 was detected in the culture supernatants by ELISA and statistically analyzed; B: Primary tumor cells were cultured with various concentrations of cytokines or monocyte-derived Tc17 cells culture supernatants, and the production of CXC12 was detected in the culture supernatants by ELISA and statistically analyzed. Comparisons were performed using the t-test. aP < 0.05; bP < 0.01. Error bars represent SE. NS: No significant difference; NM: Non-tumor tissue monocyte-derived; BM: Blood monocyte-derived; TAMs: Tumor tissue monocyte-derived.
- Citation: Zhang ZS, Gu Y, Liu BG, Tang H, Hua Y, Wang J. Oncogenic role of Tc17 cells in cervical cancer development. World J Clin Cases 2020; 8(1): 11-19
- URL: https://www.wjgnet.com/2307-8960/full/v8/i1/11.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i1.11